Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Comparative Hepatology|July 13, 2005
Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virusPhilippe Halfon, Marc Bourlière, Guillaume Pénaranda, et al.
European Journal of Gastroenterology & Hepatology|May 2, 2002
The antibody response to hepatitis B virus vaccination is negatively influenced by the hepatitis C virus viral load in patients with chronic hepatitis C: a case-control studyVincent Leroy, Marc Bourliere, Magali Durand, et al.
Plos One|March 14, 2012
Detection of IL28B SNP DNA from buccal epithelial cells, small amounts of serum, and dried blood spotsPhilippe Halfon, Denis Ouzan, Hacène Khiri, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 17, 2013
A tool for selecting patients with a high probability of sustained virological response to peginterferon alfa-2a (40kD)/ribavirinPeter Ferenci, Rodrigo Aires, Ioan Ancuta, et al.
Clinics and Research in Hepatology and Gastroenterology|July 19, 2014
Impact of IL28B on the treatment decision in naïve and experienced patients with genotype 1 and 4 chronic hepatitis C in real-life clinical practice: a prospective multicenter cohortPhilippe Halfon, Denis Ouzan, Tarik Asselah, et al.
Journal of Hepatology|December 13, 2006
Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis CPhilippe Halfon, Yannick Bacq, Anne De Muret, et al.
European Journal of Gastroenterology & Hepatology|September 9, 2011
A single IL28B genotype SNP rs12979860 determination predicts treatment response in patients with chronic hepatitis C Genotype 1 virusPhilippe Halfon, Marc Bourliere, Denis Ouzan, et al.
Emerging Infectious Diseases|January 25, 2008
Possible zoonotic transmission of hepatitis E from pet pig to its ownerChristophe Renou, Jean-Francois Cadranel, Marc Bourlière, et al.
Hepatology (Baltimore, Md.)|June 19, 2012
High sustained virologic response rates in rapid virologic response patients in the large real-world PROPHESYS cohort confirm results from randomized clinical trialsPatrick Marcellin, Hugo Cheinquer, Manuela Curescu, et al.
Health Science Reports|December 8, 2022
An observational, prospective, multicenter study on the utilization and effectiveness of elbasvir-grazoprevir treatment association for chronic hepatitis C in France (ZEPHYR study)Jean-Pierre Bronowicki, Patrick Miailhes, Bertrand Hanslik, et al.
Pageof 7